ISMPP Highlights
Future-Ready & In-Person at the 18th Annual Meeting!
ISMPP is thrilled to report that 595 attendees gathered at the 18th Annual Meeting of ISMPP, May 9-11, 2022, in Washington, DC – a celebrated attendance for our first in-person Annual Meeting since 2019! We were also honored that 247, over 40%, were first-time attendees to an ISMPP Annual Meeting! This article shares highlights and photos from the 18th Annual Meeting…
Author Selection Practices Recommended by ISMPP Authorship Task Force – Now Published in CMRO
Author selection based on ICMJE criterion 1 can be challenging, particularly for multicenter trials with a large number of investigators and contributors. The ISMPP Authorship Task Force was formally launched in 2019 to define author selection best practices for industry-sponsored medical publications. The recommendations were published in CMRO on April 19, 2022…
“In The Know” – Key Updates in Medical Communications
“In The Know” highlights various updates in medical publications and communications: New CHEERS 2022 Guidance, Preprints in ICMJE Recommendations, Carbon Costs of In-Person vs Virtual Medical Conferences, Readability and Format of PLS, AI-Assisted Tools in Scholarly Communications, Peer Review Congress in September 2022…
Message from Our Leadership
Robert J. Matheis
ISMPP President and CEO
News and Trends
Developing a Strategic Publication Plan: A Visual Survival Kit
Developing a strategic publication plan is vital to ensuring that key audiences can access the information they need to understand the potential benefits of a pharmaceutical product. View a stepwise visual guide on how to approach the development of a strategic publication plan and guidance around how it can then be assessed and adapted…
Getting Started: Social Media and Scientific Communications
Healthcare professionals are increasingly using social media to find relevant information that informs their practice. Alongside researchers and publishers, the pharmaceutical and biotechnology industries have a responsibility to provide healthcare professionals with trustworthy, timely and accurate scientific data about the products they research and develop, and the diseases they treat…
The Role of Preprint Servers and Publishers in Limiting Misinformation: An Interview
The opportunities for preprint servers and traditional publishers to limit misinformation for their users is an area of broad interest in the wake of the COVID-19 pandemic in 2020 and 2021, with its impact continuing into 2022 and beyond. This insightful interview was conducted with Jan Seal-Roberts and Caroline Halford of Adis, Springer Healthcare, and Richard Sever of Cold Spring Harbor Laboratory Press, bioRxiv, and medRxiv…
What Would You Do?
In our role as medical publication professionals, we may occasionally encounter situations in which it is not obvious how to ensure good publication practice. Have you ever wished you could consult the ISMPP membership for guidance when these situations arise? Here’s your opportunity!
What Would You Do? is a section of The MAP that presents case scenarios as an educational tool for medical publication professionals. The section provides a case scenario to ponder, and readers are invited to participate in a poll by selecting one of the listed solutions. Readers can also submit their thoughts on the scenario anonymously. The poll results, plus educational insights, are posted in a later issue for readers to digest.
To Use AI or To Not Use AI…for Manuscript Development?
You are a researcher working on a groundbreaking clinical study that could potentially lead to a significant advancement in the treatment of a complex disease. Some members of the research team want to use artificial intelligence (AI) to develop the first draft of the manuscript. Other team members are concerned about accuracy, interpretation, and potential bias in the content. What Would You Do?
ISMPP (pronounced IzMap) is the only nonprofit organization founded by medical publication professionals for medical publication professionals